Long-term Care Guidelines for Prostate Cancer Survivors
An estimated 2.8 million men in the United States are living with prostate cancer or have had it at one time, and that number is growing.
Report: Number of Cancer Survivors Continues to Grow
A new report by the American Cancer Society – in collaboration with the National Cancer Institute – estimates there are almost 14.5 million cancer survivors alive in the US today, and that number will grow to almost 19 million by 2024.
Why We Screen for Some Cancers and Not Others
Screening means having a test that looks for cancer or another disease in people who don’t have any symptoms.
Study: Cialis (Tadalafil) Does Not Prevent Erectile Dysfunction in Prostate Cancer Patients
Researchers from the Mayo Clinic and colleagues across the United States and Canada have found that Cialis (tadalafil) does not help men avoid erectile dysfunction after radiation therapy for prostate cancer.
Volunteers: Motivated to Help Others
Many cancer survivors are moved by their own experience to help others facing diagnosis and treatment. Find inspiration and hope in these stories of volunteers who are making a difference in the fight against cancer.
Annual Report: Cancer Death Rates in the US Continue to Decline
The rate of death from cancer in the United States continues to decline among both men and women, among all major racial and ethnic groups, and for the most common types of cancer.
Gene Test Shows Promise for Identifying Aggressive Prostate Cancer
Researchers from Columbia University have identified 3 genes they used to predict whether prostate cancer in men with low-risk disease would stay low-risk, or become more of a threat.
Living with Prostate Cancer
If you’re living with prostate cancer, you may be able to live longer and healthier by making some changes to your eating and exercise routine.
Omega-3 Fatty Acids Linked to Increase in Prostate Cancer Risk
A study conducted by researchers at cancer centers across the US has found a link between omega-3 fatty acids and an increased risk of prostate cancer.
FDA Approves Xofigo for Advanced Prostate Cancer
The US Food and Drug Administration (FDA) has approved Xofigo (radium-223 dichloride) to treat certain men with advanced prostate cancer.
Doctors’ Associations Release New Recommendations for Prostate Cancer Screening
Two physicians’ groups are recommending informed decision-making for screening for prostate cancer. This is in line with American Cancer Society guidelines for early detection of prostate cancer.
Study Confirms Long-Term Side Effects from Prostate Cancer Treatment
A new study has found that 15 years after treatment with surgery or radiation, most prostate cancer patients have sexual side effects, and many also have urinary and bowel problems.
Report Studies Link between World Trade Center Exposure and Cancer Risk
A study of people exposed to Ground Zero has found that early responders and recovery workers at site of the World Trade Center terrorist attack do not appear to have an increased risk of cancer overall thus far.
Understanding Hormone Therapy
Hormone therapies work with the natural properties of these substances to relieve symptoms and even fight diseases, including cancer.
Prostate Cancer Screening FAQ
Screening – or testing to find a disease in people without symptoms – can help find some types of cancer early, when it’s more easily treated.
Study: New Drug Enzalutamide Extends Life in Advanced Prostate Cancer
A clinical trial of the new drug enzalutamide (formerly called MDV3100) has shown it extends life by an average of 5 months in the most advanced stages of prostate cancer, even after other treatments.
Study: Surgery No Better Than Observation for Localized Prostate Cancer
A study by researchers from across the U.S. has found that men with localized prostate cancer lived just as long whether or not they had prostate-removal surgery.
New Report Tracks Growing Population of Cancer Survivors in the US
A first-ever report by the American Cancer Society and National Cancer Institute estimates there are 13.7 million cancer survivors alive in the US today, and that number will grow to almost 18 million by 2022.
Task Force Recommends Against Routine Prostate Cancer Screening
The United States Preventive Services Task Force (USPSTF) has issued new recommendations against prostate cancer screening.
Study Supports Intensity Modulated Radiation Therapy for Prostate Cancer
Researchers have found that intensity modulated radiation therapy is better at controlling localized prostate cancer than conformal radiation therapy and is just as effective as proton therapy.
Study: Dutasteride Helps Men Undergoing Active Surveillance for Prostate Cancer
Researchers in the U.S. and Canada have found that men with low-risk prostate cancer who took the drug dutasteride (Avodart) had lower rates of their cancer worsening than men who didn’t take the drug.
Study: Robotic Surgery Does Not Lessen Common Side Effects from Prostate Removal
A team led by researchers from Massachusetts General Hospital found that men were just as bothered by sexual and urinary side effects when they had robotic prostate surgery as when they had traditional surgery.
Gene Mutation Linked to Hereditary Prostate Cancer
Researchers studying why prostate cancer runs in families have found a genetic mutation that may begin to answer that question.
Study Shows Vitamin E Increases Prostate Cancer Risk
A follow-up study from a clinical trial that included 35,000 men shows that those who took vitamin E supplements were more likely to develop prostate cancer.
Sex Counseling After Prostate Treatment Helps Couples
Prostate cancer survivors and their partners had more success in recovering their sex life when they went through couples therapy, according to a study.
Combination Therapy Increases Survival in Some Prostate Cancer Patients
Combining hormone therapy with radiation can help some men with early-stage prostate cancer live longer, according to a new study.
Smokers Diagnosed With Prostate Cancer May Have Higher Death Risk
A just-released study about smoking and prostate cancer gives men one more reason to quit.
FDA Approves Zytiga for Prostate Cancer
The FDA has approved the drug Zytiga (abiraterone acetate) for some men with advanced prostate cancer who have already been treated with chemotherapy.
Study: Active Surveillance OK for Some Men with Prostate Cancer
Older men with low-grade prostate cancer who choose to closely monitor their disease rather than actively treat it (an approach known as "active surveillance”) can expect better quality of life compared to men who opted for surgery or radiation, according to an analysis based on available medical evidence on prostate cancer treatment outcomes.
New Drug for Advanced Prostate Cancer
The Food and Drug Administration (FDA) recently approved a new drug called cabazitaxel (Jevtana) for men with advanced prostate cancer.
Prostate Cancer Hormone Therapy May Increase Heart Risk
While hormone therapy is beneficial for many men with prostate cancer, there is growing concern that it may increase heart disease risk factors, according to a report by leading health organizations.
Annual Report: US Cancer Death Rates Still Declining
While cancer remains a major public health problem in the United States, cancer death rates among both men and women are continuing to decline, according to the American Cancer Society's (ACS) annual cancer statistics report.
Cancer Survivors Spread Message of Early Detection
Although there are many signs the disparity gap is narrowing, cancer continues to take a hefty toll on minority communities.
Drug May Lower Prostate Cancer Risk, But Cause Other Problems
Dutasteride (Avodart), a member of a class of drugs known as 5 alpha-reductase inhibitors, may reduce prostate cancer risk in some men by as much as 23%, but taking the drug may also increase a man's risk for cardiovascular problems and of developing prostate cancers that are more likely to grow and spread, the study showed.
Revised Prostate Cancer Screening Guidelines: What Has—and Hasn't—Changed
Men should discuss the benefits and risks of prostate cancer screening with their doctors, according to revised prostate cancer screening guidelines from the American Cancer Society (ACS).
Study Shows Regular Exercise Benefits Prostate Cancer Survivors
A new study shows that even a moderate amount of exercise – taking regular walks, for example – reduced overall mortality rates in men with prostate cancer. The more vigorous the exercise, the greater the benefits, the study found.
Overdiagnosis of Prostate Cancer Widespread, Study Finds
Over the last 20 years, the number of men who have been diagnosed with prostate cancer has increased, due in large part to widespread screening using the prostate-specific antigen (PSA) blood test.
Common Prostate Cancer Questions Answered
Prostate cancer affects nearly 200,000 men in the United States every year. The good news is that more than 2 million men in the United States who have been diagnosed with prostate cancer at some point in their lives are still alive today.
Heavy Alcohol Use May Increase Prostate Cancer Risk
Men who drink alcohol heavily and on a regular basis may be putting themselves at increased risk for prostate cancer, according to a new study published in Cancer, the American Cancer Society's peer-reviewed medical journal.
Experimental Vaccine Offers Hope to Men with Advanced Prostate Cancer
Dendreon Corporation recently reported encouraging phase III study results for Provenge, a “vaccine” that uses a patient's own immune system to fight advanced prostate cancer.
Prostate Cancer Screening: Weigh Risks, Benefits With Your Doctor
The debate over prostate cancer screening still rages on.
Prostate Cancer Screening: What Do the Recent Studies Mean?
Two important studies about prostate cancer were published online March 18, 2009 in the New England Journal of Medicine.
Molecule Linked With Advanced Prostate Cancer
Men whose urine contains a high concentration of a molecule called sarcosine appear to be more likely to have advanced prostate cancer, according to a study from University of Michigan researchers.
Prostate Cancer Prevention: The Scoop on Supplements
You may have heard that taking certain vitamin or mineral supplements can lower prostate cancer risk.
FDA Approves New Drug for Advanced Prostate Cancer
The US Food and Drug Administration recently approved a new drug for the treatment of advanced prostate cancer.
Major Study of Supplements and Prostate Cancer Halted
The National Cancer Institute has stopped a major clinical trial studying whether vitamin E and selenium can prevent prostate cancer because early analysis suggests the supplements don't work.
New Prostate Cancer Drug Shows Promise
Promising--yet preliminary--results from an early clinical trial show that the experimental drug abiraterone can significantly reduce the size of prostate cancer tumors in men who haven't responded to other therapies.
Hormone Therapy Not Shown to Benefit Older Patients with Early Prostate Cancer
A study of nearly 20,000 men aged 66 and older with early-stage prostate cancer found that those who were prescribed androgen deprivation hormone therapy instead of other treatments were no better off than their counterparts who adopted a "wait and see" approach.
Prostate Cancer Patients Pick Treatments That May Worsen Quality of Life
Men with early-stage prostate cancer frequently choose treatments that worsen problems they already have, according to a new study published in Cancer.
Studies Help Clarify Link Between Obesity and Prostate Cancer
Substantial evidence from clinical trials has established that obesity significantly increases the risk for heart disease and diabetes.
Study Questions Benefit of PSA Tests
Summary: Screening for prostate cancer by measuring blood levels of prostate-specific antigen (PSA) doesn't cut down on deaths from the disease, according to a study in the Archives of Internal Medicine.
Three New Studies Help Prostate and Breast Cancer Patients
To help prostate and breast cancer patients with these issues, researchers at the University of Colorado, Mount Sinai School of Medicine, and the University of California Los Angeles (UCLA) have joined forces with the National Cancer Institute’s Cancer Information Service to create 3 studies.